Member Info for Pingu777

He didnt say it would be submitted by the end of May. He said the PIND meeting would be concluded by the end of May.

Which it has been remotely. And there are workflows that need concluding including manufacturing to complete the IND. Which was always going to be the case and pharma investors know this. We are going to produce our own drugs which will save lots of cash! Amazing I hear you say. But it will take time to prove that the new lab can deliver. Read up on INDs.

When you have a grasp of how pharma works you'll have a reasonable idea about all this stuff.

The folk buying to hold for a year are laughing. The folk wanting news every other day laugh a lot less. But the daily grapple for news is real - as is the know it all sniping - very lol. But each to their own. Broaden your horizons people!

Have a great long bank holiday weekend everyone and enjoy the jubilee.

His excitement and drive when he speaks always impress me. I trust him. Glad to hear he's enjoyed London so far too. Nice to hear from Charles and Peter also.

Big things ahead for HEMO. Uber confident.

It was nice to say hi to Vlad.

1. Done
2. When its ready
3. When its ready
4. Not yet, discussions are ongoing

We need to keep expectations of the IND app submission realistic. The app has to be entirely complete before it can be sent. We dont have all the staff recruited for the manufacturing lab yet as you've pointed out. Manufacturing is an integral part of the IND app as HEMO are producing the cells themselves in-house. All test runs on production of the drug have to prove they can produce the cells cleanly.

Market sentiment needs to change from bears to bulls at some point.

Investors appetite for risk is on the floor. Most junior pharmas taking the sting over the last 12 months

DDDD, TILS, N4P, AVACTA (in the midst of a recovery) etc

HEMO has the goods and is going well. Just needs time as always. We want them to produce a $1b+ drug or process then we need them to do it properly!!

To the ignorant! ;-)

Focus your energy on a hobby maybe. Fishing? Cricket?

Log back in once a month. Sit back and relax. Analysing every trade is pointless as everyone continues to point out. You should be invested for the target projects at HEMO, which all take time. You know where they are up to. Stop going on about pointless stuff and chill out.

People will sell whenever they want

This is a still a fearful and defensive market

Cash is King for many. Personal circumstances often demand sales! Maybe they even made a profit from the other week?

Who knows. I really don’t care. Good luck to all.

Agreed Tillywhiz
It wont be a linear rise to 50p plus on developing a working drug or platform. But it has to start moving up at some point!
Hope investors keep the faith and can hold long enough to see HEMO blossom.
Agree it cant be £15m market cap for too much longer.

I think investors personal timelines heavily effect their views on HEMOs perceived success. Those accumulating stock at these prices and putting away for a few years will be the ones laughing.

Those wanting quick progress have been left frustrated sadly. But it is pharma after all. I dont imagine discovering cancer ending drugs is an easy process.

The current SP doesn't make it a bad investment even if you bought at 10p. That is, providing you are holding for 3-5 years. They'll be a bit anyed they have missed the cheap shares but not arguing on forums daily. Those who need their capital back in the short term are under pressure. That is not Vlad's fault.

I am WAY down from initial investments from way back when. However, I keep trying to accumulate more cheap ones as each month passes by. My son's JISA can wait as long as it takes for HEMO to succeed, he's only 4 haha

As Vlad said, its billions and years after all.

Oh of course Peter

Vlad has already told us in his last interview that he is indeed talking to other companies about CBR. Albeit at early stages .

Time will tell.

And lets all try not respond to him directly. He craves air time. Like a fire, lets deprive him of oxygen.

I think this needs another bump for good measure.

No one who has invested £70k comes on here moaning to the ends of the earth about the company and pontification whether to sell 300 times over months and months. Making statements to which no one what responses he wants or expects to get. Its pure negative spamming.

He's a trader who witters when hes out and refers to his 'clever friend' when he is in. I dont dislike anyone trying to make money trading HEMO. What I don't like is frauds peddling BS to further their agenda.

This guy is NOT a genuine investor. Never regard his posts as anything other that him being 'in' or 'out' depending on the negative and positive twist to his posts. (not so much positive with the current SP)

Genuine holders, things are getting better every month. This stock gets more and more undervalued as each week passes and the company close on trials of SAFE HEMO CAR T.

I agree Chris. Keep your investment time horizons realistic and all will be well. Its quite simple. Our time comes ever closer.

Dont feed the troll.

Who says they’re not looking?

Some support at this stage seems pointless to me. It is all dependent upon the progress of the science.

We are still pre clinical as I said. Nothing has changed for a long while. The action begins when we go clinical. Then new doors start to open and Vlad will need help explore them all!

So everyone would be happy to spend vital resource for trials on additional Senior Management positions? In the past HEMO has never had the funds.

Now, you could say they have.

So what should be the CEOs priority at this point in its evolution? Marketing, a COO a hands on MD? None of these people would effect the progress of the science, the integral part of HEMO's potential. But I bet they would be demanding sizeable salaries. Trials are imminent (in pharma terms ;-) and I believe the shouted for PR will arrive at that point. We have been pre clinical for so long there is nothing new to tell the market. That will change when FDA give us the nod ;-)

IMO I'd suggest Vlad's priorities should be:

1. Making the remaining cash last as long as possible with HEMO CAR T phase 1/2a trials in mind. This is the golden goose right now. Cash keeps the wheels turning.
2. Do whatever it takes to get our IND app to get the green light for trials via FDA. I am sure we are already all over this.
3. Have a planned strategy to secure non-dilutive funding when those options become available in our trajectory. (I understand we are on this as well)
4. Impress and wow the potential suitors in the ongoing CBR platform talks with other pharma with whom we wish to partner up and secure ongoing funding of that project via that route. "Talking to governments"?! Sounds very exciting. You'd think there wouldn't be a government clambering for some sort of 'defence' against future viruses after COVID 19.
5. CDX can come right back into focus once HEMO CAR T hits trials. In my view Vlad will be looking to partner up with CDX too for different specific diseases that CDX can treat with different partners (Hopefully!!!). We certainly wont be raising to take CDX forward at this SP as they simply wont get what they need. The SP has to be a great deal higher for that sort of raise.

Anyhow, HEMO remains a pearl of an investment. Some peripheral stuff continues to P!55 me off (the last interview was very poor imo) but the fundamental scientific pre clinical breakthroughs are novel and 100% required by the human race. The world needs HEMO CAR T, a CBR platform for disease X and CDX Monoclonal antibodies to support the medical profession save more peoples lives.